天华新能 reported revenue of ¥7.78B for the period ended 2026-06-30, +125.0% year on year. Net income was ¥2.60B, a 33.4% net margin on a 43.5% gross margin. The largest revenue line is 锂电材料 at 94% of the total. Free cash flow for the period was ¥0.15B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥7.78B | +125.0% |
| Gross profit | ¥3.38B | — |
| Operating income | ¥3.07B | — |
| Net income | ¥2.60B | — |
| Gross margin | 43.5% | Net margin 33.4% |
| Revenue Q/Q | +43.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 锂电材料 | ¥7.32B | 94.0% |
| 其他主营业务 | ¥0.45B | 5.8% |
| 其他(补充) | ¥0.01B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.40B | 56.5% |
| R&D | ¥0.04B | 0.5% |
| SG&A | ¥0.24B | 3.1% |
| Tax & other | ¥0.47B | 6.0% |
| Item | Amount |
|---|---|
| Total assets | ¥27.92B |
| Total liabilities | ¥9.52B |
| Shareholders' equity | ¥18.39B |
| Equity / assets | 65.9% |
| Operating cash flow | ¥0.36B |
| Capital expenditure | ¥0.21B |
| Free cash flow | ¥0.15B |
| Cash conversion (OCF / net income) | 7% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中来股份 ・ 菲利华 ・ ST迪瑞 ・ 天和防务 ・ 飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies